Weighing dose‐related benefits and risks of hydroxychloroquine treatment in systemic lupus erythematosus patients

Journal:

Arthritis & Rheumatology

Published:

2025-12-21

DOI:

10.1002/art.70022

Affiliations:

7

Authors:

6

Go to article

Institutions	Authors	Share
National Cheng Kung University (NCKU), Taiwan	3.333333	0.56
National Cheng Kung University Hospital, Taiwan	1.333333	0.22
University of Illinois at Chicago (UIC), United States of America (USA)	1.000000	0.17
Stanford Medicine, United States of America (USA)	0.333333	0.06

Interested in Pharmacology and Pharmaceutical Sciences?